Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
Filed	Form	What it is	Accession number
2020-11-0508:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-20-007636
2020-09-1507:32 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000140
2020-08-2708:17 ET	8-K	8.01 Other events	0001447028-20-000135
2020-08-1006:44 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000129
2020-08-0717:24 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001447028-20-000126
2020-08-0716:24 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001447028-20-000118
2020-08-0707:34 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001447028-20-000100
2020-07-2421:13 ET	8-K	8.01 Other events	0001447028-20-000078
2020-06-0117:12 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001447028-20-000071
2020-05-1817:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000052
2020-05-1116:07 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001447028-20-000049
2020-05-1108:29 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001447028-20-000046
2020-04-2408:02 ET	DEF 14A	Proxy statementPeriod 2020-05-28	0001047469-20-002560
2020-03-2617:17 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000043
2020-03-0616:06 ET	10-K/A	Annual report, amendedPeriod 2019-12-31	0001447028-20-000041
2020-03-0516:19 ET	10-K	Annual reportPeriod 2019-12-31	0001447028-20-000038
2020-03-0507:33 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001447028-20-000035
2020-02-1908:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001447028-20-000024
2020-02-1008:05 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000009
2020-01-1308:45 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001447028-20-000006
2019-12-2316:09 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001447028-19-000081
2019-11-0612:27 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001447028-19-000071
2019-11-0607:34 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001447028-19-000069
2019-10-0316:16 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001447028-19-000064
2019-08-2616:14 ET	8-K	8.01 Other events	0001447028-19-000060
2019-08-2016:09 ET	8-K	5.02 Departure or appointment of officers or directors	0001447028-19-000049
2019-08-0916:05 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-045102
2019-08-0512:29 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001447028-19-000025
2019-08-0511:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-19-005142
2019-07-1816:05 ET	8-K	8.01 Other events	0001104659-19-040934
2019-07-1717:43 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-19-040598
2019-07-1717:31 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-19-040594
2019-07-1216:57 ET	SC 13D/A	Ownership report, active investor, amended	0000903423-19-000288
2019-07-1216:47 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-19-193262
2019-07-1216:45 ET	SC 13D/A	Ownership report, active investor, amended	0001144204-19-034587
2019-07-1216:34 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-19-193243
2019-07-0316:28 ET	8-K	1.01 Entry into a material agreement	0001171843-19-004412
2019-06-1816:00 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-19-004042
2019-05-2816:53 ET	8-K	5.07 Shareholder vote results	0001447028-19-000018
2019-05-2006:07 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-030387
2019-05-0617:30 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001447028-19-000015
2019-05-0617:02 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-19-002996
2019-04-2316:04 ET	DEF 14A	Proxy statementPeriod 2019-05-22	0001047469-19-002498
2019-04-2316:01 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001104659-19-023074
2019-03-1514:03 ET	8-K	5.02 Departure or appointment of officers or directors	0001447028-19-000010
2019-03-0717:18 ET	10-K	Annual reportPeriod 2018-12-31	0001447028-19-000006
2019-03-0716:29 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-19-001586
2019-02-1417:55 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-008025
2019-01-0317:22 ET	SC 13D/A	Ownership report, active investor, amended	0000903423-19-000004
2018-12-2016:06 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001104659-18-074112

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.